1. Home
  2. PRCT vs QDEL Comparison

PRCT vs QDEL Comparison

Compare PRCT & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$34.66

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

HOLD

Current Price

$33.35

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCT
QDEL
Founded
2009
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
PRCT
QDEL
Price
$34.66
$33.35
Analyst Decision
Buy
Hold
Analyst Count
9
6
Target Price
$51.13
$39.33
AVG Volume (30 Days)
1.2M
849.5K
Earning Date
02-24-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$299,907,000.00
$2,714,400,000.00
Revenue This Year
$48.30
N/A
Revenue Next Year
$29.44
$2.42
P/E Ratio
N/A
N/A
Revenue Growth
50.07
N/A
52 Week Low
$27.80
$19.50
52 Week High
$89.30
$49.45

Technical Indicators

Market Signals
Indicator
PRCT
QDEL
Relative Strength Index (RSI) 56.17 71.90
Support Level $30.60 $27.93
Resistance Level $35.40 $29.62
Average True Range (ATR) 1.44 1.32
MACD 0.13 0.37
Stochastic Oscillator 83.75 92.33

Price Performance

Historical Comparison
PRCT
QDEL

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.

Share on Social Networks: